No Data
Merck Analysts Slash Their Forecasts After Q2 Results
Merck Is Maintained at Buy by B of A Securities
Merck Price Target Cut to $145.00/Share From $150.00 by B of A Securities
UBS Maintains Buy on Merck & Co, Lowers Price Target to $142
Merck & Co Analyst Ratings
Analyzing Merck & Co In Comparison To Competitors In Pharmaceuticals Industry